RNVA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RNVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Rennova Health's Net Income for the three months ended in Dec. 2023 was $-9.26 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was $-7.73 Mil.
Net Income is linked to the most popular Earnings per Share (Diluted) number. Rennova Health's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $-0.00.
The historical data trend for Rennova Health's Net Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rennova Health Annual Data | |||||||||||||||||||||
Trend | Mar14 | Mar15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Net Income | Get a 7-Day Free Trial |
![]() |
![]() |
-48.03 | -18.34 | 5.61 | -3.29 | -7.73 |
Rennova Health Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Net Income | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.82 | 0.81 | 1.28 | -0.55 | -9.26 |
Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.
Net Income
= Revenue
- Cost of Goods Sold
- Selling, General, & Admin. Expense
- Research & Development
- Depreciation, Depletion and Amortization
- Interest Expense
- Non Operating Income (NRI) - Tax Expense + Others
= EBITDA
- Depreciation, Depletion and Amortization
- Interest Expense
- Non Operating Income (NRI) - Tax Expense + Others
= Operating Income
- Interest Expense
- Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others
Rennova Health's Net Income for the fiscal year that ended in Dec. 2023 is calculated as
Net Income | (A: Dec. 2023 ) | ||||||
= | Pre-Tax Income | + | Tax Provision | + | Net Income (Discontinued Operations) | + | Others |
= | -0.314 | + | -0.24 | + | -7.195 | + | 0.02 |
= | -7.73 |
Rennova Health's Net Income for the quarter that ended in Dec. 2023 is calculated as
Net Income | (Q: Dec. 2023 ) | ||||||
= | Pre-Tax Income | + | Tax Provision | + | Net Income (Discontinued Operations) | + | Others |
= | -2.182 | + | 0.093 | + | -7.186 | + | 0.011000000000001 |
= | -9.26 |
Net Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.73 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rennova Health (OTCPK:RNVA) Net Income Explanation
Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:
Rennova Health's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2023 is calculated as
Earnings per Share (Diluted) (Q: Dec. 2023 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Diluted Average) |
= | (-9.264 | - | 0) | / | 40551.322 | |
= | -0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
EPS is most useful for companies that have:
A predictable businessThe dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
Thank you for viewing the detailed overview of Rennova Health's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Jonathan Immordino | officer: Chief Financial Officer | 3340, POSEIDON WAY, INDIALANTIC FL 32903 |
Marlene Mclennan | officer: Chief Financial Officer | 400 SOUTH AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401 |
Gary L Blum | director | 3278 WILSHIRE BOULEVARD, SUITE 603, LOS ANGELES, CALIFORNIA CA 90010 |
John Beach | director | 400 S. AUSTRALIAN AVENUE,, SUITE 800,, WEST PALM BEACH, FL 33401 |
Kamran Ajami | director | 3920 NW 43RD ST., COCONUT CREEK FL 33073 |
Trevor Langley | director | 1000 N. GREEN VALLEY PARKWAY, #440-420, HENDERSON NV 89074 |
Michael H Pollack | officer: Interim CFO | 114 WEST 47TH STREET, 19TH FLOOR, NEW YORK NY 10036 |
Sharon Lynne Hollis | 10 percent owner | 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401 |
Robert P Lee | director | 400 S. AUSTRALIAN AVE., #800, WEST PALM BEACH FL 33134 |
Aella, Ltd. | 10 percent owner | SUITE 104A, SAFFREY SQUARE, BANK LANE, PO BOX N-9306, NASSAU C5 000000 |
Epizon Ltd. | 10 percent owner | SUITE 104A, SAFFREY SQUARE, BANK LANE, PO BOX N-9306, NASSAU C5 000000 |
Michael Louis Goldberg | director | 2008 BAYVIEW DRIVE, FORT LAUDERDALE FL 33305 |
Benjamin Frank | director | 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401 |
Jason Adams | officer: Chief Financial Officer | 4700 SANTA DEL RAE AVENUE, FT MYERS FL 33901 |
George Lundberg | officer: Editor in Chief and CMO | 44 MONTGOMERY STREET, SUITE 800, SAN FRANCISCO CA 94104 |
From GuruFocus
By Marketwired Marketwired • 08-16-2018
By sperokesalga sperokesalga • 06-13-2023
By Marketwired Marketwired • 09-03-2019
By Marketwired Marketwired • 06-11-2019
By Marketwired Marketwired • 02-26-2019
By Marketwired Marketwired • 09-02-2020
By Marketwired • 08-21-2023
By Marketwired • 10-25-2023
By Marketwired Marketwired • 07-01-2019
By Marketwired Marketwired • 06-22-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.